SOLENO THERAPEUTICS INC (SLNO) Stock Earnings & Estimates
NASDAQ:SLNO - US8342033094 - Common Stock
66.51 USD
-2.06 (-3%)
66.51 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 610K | 1.649M -100.00% | 271.32K | 144.11M | 396.86M 175.39% | 661.11M 66.59% | |||||||||
| EBITDA YoY % growth | -5.13M | -12.05M -134.89% | N/A 32.03% | N/A -28.94% | N/A -16.86% | N/A -74.47% | N/A -59.50% | N/A 13.89% | N/A 24.11% | N/A -75.70% | N/A -370.97% | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.16M | -12.16M -135.66% | -14.59M 31.58% | -10.821M -46.27% | -18.473M -17.50% | -23.829M -64.27% | -37.078M -54.49% | -36.973M 13.12% | -26.45M 22.61% | -37.192M -69.61% | -180.712M -353.49% | -98.422M 47.56% | 73.414M 174.59% | 334.72M 355.93% | |
| Operating Margin | N/A | -1,993.44% | -884.78% | -3,988.35% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -68.30% | 18.50% | 50.63% | |
| EPS YoY % growth | N/A | N/A | -82.62 56.28% | -18.21 67.27% | -14.99 38.30% | -10.20 13.97% | -6.83 48.84% | -6.66 11.36% | -3.50 43.25% | -2.52 10.54% | -4.31 -43.43% | -1.06 75.22% | 2.67 352.60% | 6.20 132.36% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 95.70% | 0.10 108.23% | 0.24 125.23% | 0.56 723.33% | 0.95 1,312.08% | 1.25 1,096.75% |
| Revenue Q2Q % growth | 47.488M | 63.245M | 73.648M | 96.255M 194.75% | 125.02M 163.27% | 143.5M 126.90% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.057M 92.45% | -14.137K 99.98% | -373.065K 99.18% | 15.215M 333.18% | 41.347M 782.63% | 57.045M 403,609.89% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.09 84.21% | -0.47 | 0.38 | 80.77% |
| Q1 2025 Q2Q % growth | -0.95 -61.02% | -0.95 | 0.00 | -0.42% |
| Q4 2024 Q2Q % growth | -1.27 -284.85% | -1.18 | -0.09 | -7.96% |
| Q3 2024 Q2Q % growth | -1.83 -92.63% | -0.64 | -1.19 | -186.49% |
| Q2 2024 Q2Q % growth | -0.57 29.63% | -0.61 | 0.04 | 6.60% |
| Q1 2024 Q2Q % growth | -0.59 32.95% | -0.38 | -0.21 | -57.04% |
| Q4 2023 Q2Q % growth | -0.33 43.10% | -0.28 | -0.05 | -18.37% |
| Q3 2023 Q2Q % growth | -0.95 -25.00% | -0.59 | -0.36 | -61.51% |
| Q2 2023 Q2Q % growth | -0.81 10.00% | -0.84 | 0.03 | 3.94% |
| Q1 2023 Q2Q % growth | -0.88 18.52% | -0.74 | -0.14 | -19.00% |
| Q4 2022 Q2Q % growth | -0.58 3.33% | -0.82 | 0.24 | 28.92% |
| Q3 2022 Q2Q % growth | -0.76 49.33% | -0.93 | 0.17 | 18.12% |
| Q2 2022 Q2Q % growth | -0.90 57.14% | -0.92 | 0.02 | 1.96% |
| Q1 2022 Q2Q % growth | -1.08 34.55% | -1.07 | -0.01 | -0.84% |
| Q4 2021 Q2Q % growth | -0.60 | -1.30 | 0.70 | 53.86% |
| Q3 2021 Q2Q % growth | -1.50 9.09% | -1.68 | 0.18 | 10.87% |
| Q2 2021 Q2Q % growth | -2.10 12.50% | -1.63 | -0.47 | -28.67% |
| Q1 2021 Q2Q % growth | -1.65 15.38% | -1.17 | -0.48 | -40.66% |
| Q4 2020 Q2Q % growth | -0.60 88.89% | -1.07 | 0.47 | 43.98% |
| Q3 2020 Q2Q % growth | -1.65 -466.67% | -1.33 | -0.32 | -24.43% |
| Q2 2020 Q2Q % growth | -2.40 48.39% | -3.14 | 0.74 | 23.48% |
| Q1 2020 Q2Q % growth | -1.95 40.91% | -3.01 | 1.06 | 35.20% |
| Q4 2019 Q2Q % growth | -5.40 | -2.45 | -2.95 | -120.59% |
| Q3 2019 Q2Q % growth | 0.45 | -2.45 | 2.90 | 118.38% |
| Q2 2019 Q2Q % growth | -4.65 | -2.68 | -1.97 | -73.67% |
| Q1 2019 Q2Q % growth | -3.30 | -4.44 | 1.14 | 25.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 32.657M | 25.645M | 7.012M | 27.34% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 80.83% | 86.23% | 67.05% | 65.1% |
| Revenue | 40.33% | 472.97% | 192.14% | 216.56% |